1. Short title This Act may be cited as the Pharmaceutical Regulation Conflict of Interest Act . 2. Requirements relating to slowing the revolving door among pharmaceutical regulators The Ethics in Government Act of 1978 (5 U.S.C. App.) is amended by adding at the end the following: VI Special requirements for pharmaceutical regulators 601. Definitions (a) In general In this title, the terms designated agency ethics official and executive branch have the meanings given those terms under section 109. (b) Other definitions In this title: (1) Covered pharmaceutical regulator The term covered pharmaceutical regulator means an officer or employee of a covered pharmaceutical regulatory agency who occupies— (A) a supervisory position classified at or above GS–13 of the General Schedule; (B) in the case of a position not under the General Schedule, a supervisory position for which the rate of basic pay is not less than the minimum rate of basic pay for GS–13 of the General Schedule; or (C) any other supervisory position determined to be of equal classification by the Director. (2) Covered pharmaceutical regulatory agency The term covered pharmaceutical regulatory agency — (A) means an agency whose primary responsibility is to regulate the manufacture, distribution, or sale of drugs (as defined in section 201 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321 )) or biological products (as defined in section 351 of the Public Health Service Act ( 42 U.S.C. 262 )); and (B) includes— (i) the Drug Enforcement Administration; and (ii) the Food and Drug Administration. (3) Director The term Director means the Director of the Office of Government Ethics. (4) Former client The term former client — (A) means a person for whom the covered pharmaceutical regulator served personally as an agent, attorney, or consultant during the 2-year period ending on the date (after such service) on which the covered pharmaceutical regulator begins service in the Federal Government